Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company. The board comprises executive, non-executive, and independent non-executive directors, each serving on various committees such as the Audit, Remuneration and Appraisal, Nomination, and Scientific Committees. This announcement provides clarity on the governance structure of TYK Medicines, potentially impacting its strategic direction and operational efficiency.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 2,740,401
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.58B
See more data about 2410 stock on TipRanks’ Stock Analysis page.